CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $10.18M in the quarter ending June 30, 2026, with 1,041.37% growth. This brings the company's total for the last twelve months to $13.39M, down -64.80% year-over-year. In the year 2025, CRISPR Therapeutics AG had annual revenue of $3.51M, down -90.59%. That makes CRISPR Therapeutics AG the 35,968th largest company in the world by revenue and 4,723rd in the United States.

• Revenue (ttm): $13.39M
• Revenue Growth: -64.80%
• P/S Ratio: 371.91
• Revenue / Employee: $34,076
• Employees: 393
• Market Cap: 4.97B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Collaboration 35.00M 93.8%
• Grant 2.31M 6.2%

Fiscal year ended Dec 31, 2024 See the full CRISPR Therapeutics AG breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.51M	-33.80M	-90.59%
Dec 31, 2024	37.31M	-333.89M	-89.95%
Dec 31, 2023	371.21M	370.01M	30,885.48%
Dec 31, 2022	1.20M	-913.77M	-99.87%
Dec 31, 2021	914.96M	914.24M	127,154.94%
Dec 31, 2020	719.00K	-288.87M	-99.75%
Dec 31, 2019	289.59M	286.47M	9,169.85%
Dec 31, 2018	3.12M	-37.87M	-92.38%
Dec 31, 2017	41.00M	35.83M	693.90%
Dec 31, 2016	5.16M	4.92M	1,990.69%
Dec 31, 2015	247.00K	-	-
Dec 31, 2014	-	-	-

Data Source: Fiscal.ai Last updated: Aug 3, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error